Clinical Trial Update: Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy of a triple-drug regimen (darunavir/ritonavir, etravirine, and raltegravir) in HIV patients with resistant viruses has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• darunavir/ritonavir (darunavir/ritonavir)
• etravirine (etravirine)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED